James Treanor, CEO of ADRx, describes a molecule in a drug the company is researching. James Treanor opened a space-age refrigerator in a lab in Thousand Oaks. Behind a glass door sat dozens of Petri dishes filled with a dark pink liquid and cancer cells of all shapes and sizes. Under a high-powered microscope, globs…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
